GVQW3

Model summary

A nucleoplasmic scaffold that enforces nuclear RNA quality control by organizing assemblies that degrade aberrant transcripts produced by RNA polymerase II and III. It uses an HTH-driven RNA/protein-binding platform to recruit and stabilize decay machinery, thereby promoting RNA catabolism and maintaining transcriptome fidelity within the nucleus.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminus carries IPR041426 (Mos1 transposase, HTH domain, residues 9–53), a helix-turn-helix module that imposes sequence-specific nucleic-acid recognition and often mediates assembly of higher-order ribonucleoprotein complexes. This HTH sits within a larger framework annotated as IPR052709 (Transposase-Methyltransferase Hybrid family, residues 1–222), indicating an evolutionary origin from transposase/methyltransferase fusions. Such hybrids typically repurpose DNA/RNA-binding HTH scaffolds to organize RNA-processing assemblies rather than catalyze methyl transfer in metazoan nuclei. The ordered layout—an N-terminal HTH followed by the hybrid-family core—creates a bipartite platform: the HTH domain nucleates binding to structured RNAs or RNA–protein complexes, while the hybrid scaffold stabilizes multivalent interactions with other factors.

2. 02

   This architecture causes a molecular function centered on multivalent assembly rather than enzymatic chemistry.

   The HTH and hybrid scaffold together drive GO:0005515 protein binding by recruiting and stabilizing RNA-processing partners. The absence of catalytic motifs for nuclease or methyltransferase activity and the presence of an HTH strongly argue that the protein acts as an adaptor/scaffold that organizes effector complexes.

3. 03

   From this binding-centric function, the biological process follows.

   The protein is required for the RNA catabolic pathway that eliminates aberrant and pervasive transcripts, including pervasive non-coding transcripts and antisense RNAs generated by RNA polymerase II and III. By scaffolding RNA-decay machinery, it channels these RNAs into GO:0006401 RNA catabolic process. The HTH-guided assembly of ribonucleoprotein complexes provides the selectivity and throughput needed to surveil and dismantle defective or excess nuclear RNAs.

4. 04

   Cellular localization is dictated by function and architecture.

   Transposase-derived RNA-binding scaffolds typically operate in the nuclear interior where nascent transcripts emerge and are processed. The soluble, non-membranous nature of the HTH/hybrid framework and its role in RNA quality control place the protein in the GO:0005654 nucleoplasm, consistent with a nuclear residence.

5. 05

   Mechanistically, I hypothesize that the HTH domain recognizes structured or motif-bearing regions within aberrant nuclear RNAs and seeds assembly of decay modules.

   Likely partners include nuclear RNA surveillance and turnover systems—such as the nuclear RNA exosome (e.g., catalytic and core subunits), RNA helicases that remodel RNPs, and polyadenylation/nuclear-adenosine-modifying factors that license decay. By bridging these assemblies, the protein enforces fidelity of the transcriptome emerging from RNA polymerase II and III by routing defective RNAs toward nucleoplasmic degradation pathways.